NCT06745583 2026-04-09
A Phase 2 Study to Assess the Safety of EI-1071 and the Effects of EI-1071 on Neuroinflammation in Alzheimer's Disease Patients
Elixiron Immunotherapeutics (Hong Kong) Ltd.
Phase 2 Recruiting
Clinical Trials
26 trialsNCT05894954 2026-02-18
EVANTHEA
Alzheimer's Prevention and Reversal Project, Inc.
Phase 3 Completed
NCT06125951 2026-02-18
XanaMIA
Actinogen Medical
Phase 2/3 Active not recruiting
NCT05637801 2026-02-05
Hope
Cognito Therapeutics, Inc.
Phase NA Active not recruiting
NCT06723015 2025-11-18
Tau PET Outcomes With Anti-amyloid Immunotherapies
Mayo Clinic
Phase 2 Enrolling by invitation
NCT04971733 2025-06-10
A Study to Assess Safety and Target Engagement of E2814 in Participants With Mild to Moderate Cognitive Impairment Due to Dominantly Inherited Alzheimer's Disease
Eisai Inc.
Phase 1/2 Completed
NCT05328115 2025-01-31
A Study on the Safety, Tolerability and Immunogenicity of ALZ-101 in Participants With Early Alzheimer's Disease
Alzinova AB
Phase 1 Completed
NCT06362707 2024-10-22
FEAD
Helse Stavanger HF
Phase 2 Recruiting
NCT04313582 2024-07-16
SmartPrompt
Temple University
Phase NA Completed
NCT04315337 2024-07-16
VKI
Temple University
Phase NA Completed
NCT06444841 2024-07-09
Paper-Based and Smartphone-Based Memory Supports
Baylor University
Phase NA Recruiting
NCT06245031 2024-05-07
Extension to a Pivotal Study of Sensory Stimulation in Alzheimer's Disease (OLE Hope Study, CA-0015)
Cognito Therapeutics, Inc.
Phase NA Enrolling by invitation
NCT04531956 2024-01-23
S-DeciDeD
Maastricht University
Phase NA Completed
NCT05165186 2023-10-19
Care Planning for a Loved One With Dementia: Knowledge, Preparing for Decisions, and Emotions
Massachusetts General Hospital
Phase NA Unknown
NCT05343611 2023-06-23
Choko-AGE
Universita di Verona
Phase NA Unknown
NCT03371420 2023-04-18
PET Imaging of Subjects Using 124I-PU-AD
Samus Therapeutics, Inc.
Phase EARLY_PHASE1 Terminated
NCT04942184 2022-11-01
STRATEGIES to Improve Memory in Alzheimer's Disease
Boston University
Phase NA Withdrawn
NCT04828434 2022-03-25
V-iCST
University College, London
Phase NA Unknown
NCT03556280 2021-08-24
Overture
Cognito Therapeutics, Inc.
Phase NA Active not recruiting
NCT03661034 2021-08-24
Study of Tolerability, Safety and Efficacy of Sensory Stimulation at Multiple Dose Levels to Improve Brain Function (Etude Study)
Cognito Therapeutics, Inc.
Phase NA Unknown
NCT03384043 2020-07-08
Comparing Smartphone Technology and a Memory Strategy on Improving Prospective Memory in Alzheimer's Disease
Baylor University
Phase NA Completed
NCT00348140 2017-09-05
REFLECT-3
GlaxoSmithKline
Phase 3 Completed
NCT02859207 2017-06-08
A Study to Evaluate the Pharmacokinetics of E2609 and Its Metabolites in Subjects With Mild and Moderate Hepatic Impairment Compared With Healthy Subjects
Eisai Inc.
Phase 1 Completed
NCT00428090 2017-05-19
Rosiglitazone (Extended Release Tablets) As Monotherapy In Subjects With Mild To Moderate Alzheimer's Disease
GlaxoSmithKline
Phase 3 Completed
NCT00411580 2013-03-29
Safety and Tolerability Study in Patients With Mild to Moderate Alzheimer's Disease (AD)
Novartis
Phase 1 Completed
NCT00711204 2012-12-10
Evaluating The Impact Of Donepezil Hydrochloride (Aricept) On Behavioral And Psychological Symptoms In Patients With Severe Alzheimer's Disease
Eisai Inc.
Phase 4 Withdrawn